Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes
CA 2201282 C · Owner: Mandrand, Bernard · Inventors: Jolivet-Reynaud, Colette; Perron, Herve; Komurian-Pradel, Florence
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
iral material, in an isolated or purified state whose genome comprises a nucleotide sequence selected from the group that includes the sequences SEQ ID NO 46 SEQ ID NO 51, SEQ ID NO 52, SEQ ID NO 53 and SEQ ID NO 56 their complementary sequences, and equivalent sequences in particular, nucleotide sequences which for every series of 100 contiguous monomers show at least 50% but preferably 70% homology with the said sequences SEQ ID NO 46 SEQ ID NO 51, SEQ ID NO 52, SEQ ID NO 53 and SEQ ID NO 56 respectively and their complementary sequences.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 2, 1996 and granted April 2, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 2, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 2, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.